173 related articles for article (PubMed ID: 25199864)
1. [Radiological evaluation of the tumour response after lung stereotactic radiotherapy].
Vulquin N; Feutray S; Peignaux-Casasnovas K; Humbert O; Créhange G; Truc G; Maingon P; Martin E
Cancer Radiother; 2014 Oct; 18(5-6):414-9. PubMed ID: 25199864
[TBL] [Abstract][Full Text] [Related]
2. [Follow-up after lung stereotactic radiotherapy].
Waissi W; Noël G; Giraud P
Cancer Radiother; 2015 Oct; 19(6-7):566-72. PubMed ID: 26337472
[TBL] [Abstract][Full Text] [Related]
3. Radiological changes after stereotactic radiotherapy for stage I lung cancer.
Dahele M; Palma D; Lagerwaard F; Slotman B; Senan S
J Thorac Oncol; 2011 Jul; 6(7):1221-8. PubMed ID: 21623237
[TBL] [Abstract][Full Text] [Related]
4. Distinguishing radiation fibrosis from tumour recurrence after stereotactic ablative radiotherapy (SABR) for lung cancer: a quantitative analysis of CT density changes.
Mattonen SA; Palma DA; Haasbeek CJ; Senan S; Ward AD
Acta Oncol; 2013 Jun; 52(5):910-8. PubMed ID: 23106174
[TBL] [Abstract][Full Text] [Related]
5. [Radiation-induced lung toxicity predictors after stereotactic radiation therapy for non-small cell lung carcinoma stage I].
Menoux I; Le Fèvre C; Noël G; Antoni D
Cancer Radiother; 2018 Dec; 22(8):826-838. PubMed ID: 30337050
[TBL] [Abstract][Full Text] [Related]
6. [Assessment of the response following stereotactic irradiation of lung primary tumors and metastases].
Barillot I; Munier O; Hatime M; Mornex F
Cancer Radiother; 2014; 18(4):308-12. PubMed ID: 24746763
[TBL] [Abstract][Full Text] [Related]
7. Radiation-induced lung toxicity predictors: Retrospective analysis of 90 patients treated with stereotactic body radiation therapy for stage I non-small-cell lung carcinoma.
Menoux I; Antoni D; Mazzara C; Labani A; Charloux A; Quoix E; Falcoz PE; Truntzer P; Noël G
Cancer Radiother; 2020 Apr; 24(2):120-127. PubMed ID: 32173269
[TBL] [Abstract][Full Text] [Related]
8. Radiological assessment after stereotactic body radiation of lung tumours.
Chassagnon G; Martini K; Giraud P; Revel MP
Cancer Radiother; 2020 Aug; 24(5):379-387. PubMed ID: 32534799
[TBL] [Abstract][Full Text] [Related]
9. Stereotactic body radiotherapy for primary lung cancer at a dose of 50 Gy total in five fractions to the periphery of the planning target volume calculated using a superposition algorithm.
Takeda A; Sanuki N; Kunieda E; Ohashi T; Oku Y; Takeda T; Shigematsu N; Kubo A
Int J Radiat Oncol Biol Phys; 2009 Feb; 73(2):442-8. PubMed ID: 18990507
[TBL] [Abstract][Full Text] [Related]
10. [An analysis of 20 consecutive patients treated with stereotactic body radiotherapy on Novalis Tx(®) for stage I non-small-cell lung cancer].
Guillerme F; Clavier JB; Schumacher C; Falcoz PE; Bourrhala K; Santelmo N; Hassler S; Schott R; Quoix E; Massard G; Noël G
Cancer Radiother; 2013; 17(4):272-81. PubMed ID: 23712043
[TBL] [Abstract][Full Text] [Related]
11. Differentiation of tumor recurrence from radiation-induced pulmonary fibrosis after stereotactic ablative radiotherapy for lung cancer: characterization of 18F-FDG PET/CT findings.
Nakajima N; Sugawara Y; Kataoka M; Hamamoto Y; Ochi T; Sakai S; Takahashi T; Kajihara M; Teramoto N; Yamashita M; Mochizuki T
Ann Nucl Med; 2013 Apr; 27(3):261-70. PubMed ID: 23299492
[TBL] [Abstract][Full Text] [Related]
12. Patterns of disease recurrence after stereotactic ablative radiotherapy for early stage non-small-cell lung cancer: a retrospective analysis.
Senthi S; Lagerwaard FJ; Haasbeek CJ; Slotman BJ; Senan S
Lancet Oncol; 2012 Aug; 13(8):802-9. PubMed ID: 22727222
[TBL] [Abstract][Full Text] [Related]
13. Size matters: a comparison of T1 and T2 peripheral non-small-cell lung cancers treated with stereotactic body radiation therapy (SBRT).
Dunlap NE; Larner JM; Read PW; Kozower BD; Lau CL; Sheng K; Jones DR
J Thorac Cardiovasc Surg; 2010 Sep; 140(3):583-9. PubMed ID: 20478576
[TBL] [Abstract][Full Text] [Related]
14. Stereotactic hypofractionated radiotherapy in stage I (T1-2 N0 M0) non-small-cell lung cancer (NSCLC).
Zimmermann FB; Geinitz H; Schill S; Thamm R; Nieder C; Schratzenstaller U; Molls M
Acta Oncol; 2006; 45(7):796-801. PubMed ID: 16982542
[TBL] [Abstract][Full Text] [Related]
15. Patterns of CT lung injury and toxicity after stereotactic radiotherapy delivered with helical tomotherapy in early stage medically inoperable NSCLC.
Arcangeli S; Agolli L; Portalone L; Migliorino MR; Lopergolo MG; Monaco A; Dognini J; Pressello MC; Bracci S; Donato V
Br J Radiol; 2015 Apr; 88(1048):20140728. PubMed ID: 25645106
[TBL] [Abstract][Full Text] [Related]
16. Early metabolic response evaluation after stereotactic radiotherapy for lung cancer: pilot experience with 18F-fluorodeoxyglucose positron emission tomography-computed tomography.
Dahele M; Freeman M; Pearson S; Brade A; Cho BC; Hope A; Franks K; Purdie T; Bissonnette JP; Jaffray DA; Bezjak A; Sun A
Clin Oncol (R Coll Radiol); 2011 Jun; 23(5):359-63. PubMed ID: 21194908
[TBL] [Abstract][Full Text] [Related]
17. Maximum standardized uptake value from staging FDG-PET/CT does not predict treatment outcome for early-stage non-small-cell lung cancer treated with stereotactic body radiotherapy.
Burdick MJ; Stephans KL; Reddy CA; Djemil T; Srinivas SM; Videtic GM
Int J Radiat Oncol Biol Phys; 2010 Nov; 78(4):1033-9. PubMed ID: 20472359
[TBL] [Abstract][Full Text] [Related]
18. Clinical value of F18-fluorodeoxyglucose positron emission tomography-computed tomography in patients with non-small cell lung cancer after potentially curative surgery: experience with 241 patients.
Kanzaki R; Higashiyama M; Maeda J; Okami J; Hosoki T; Hasegawa Y; Takami M; Kodama K
Interact Cardiovasc Thorac Surg; 2010 Jun; 10(6):1009-14. PubMed ID: 20197344
[TBL] [Abstract][Full Text] [Related]
19. Lung metastases treated with image-guided stereotactic body radiation therapy.
Baschnagel AM; Mangona VS; Robertson JM; Welsh RJ; Kestin LL; Grills IS
Clin Oncol (R Coll Radiol); 2013 Apr; 25(4):236-41. PubMed ID: 23352916
[TBL] [Abstract][Full Text] [Related]
20. [Stereotactic radiotherapy for stage I and II lung cancer: a study of 33 patients].
Champeaux-Orange E; Wachter T; Bouscayrol H; Barillot I
Cancer Radiother; 2011 Jun; 15(3):192-6. PubMed ID: 21330178
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]